RevealDx launches lung nodule viewer, AI monitoring dashboard

Lung nodule AI developer RevealDx is introducing two products for lung imaging and AI.

The products include ReViewer, a diagnostic-quality image viewer for identifying and quantifying lung nodules, and ReViz, a quality assurance and practice management dashboard for monitoring AI performance.

ReViewer allows the company’s RevealAI-Lung software to be deployed in any PACS, while ReViz lets healthcare providers track AI performance. Customers can continue to use third-party nodule detection and management systems, the company said.

RevealAI-Lung received clearance from the U.S. Food and Drug Administration (FDA) in 2026 for use with incidentally detected lung nodules. RevealDx said it also plans to offer its RevealAI-Screen lung cancer screening software to U.S. patients at no charge, pending FDA clearance.

Page 1 of 421
Next Page